Skip to main content
Toggle navigation
Login
Search
Home
Tweets by RAPS Convergence 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Attendees who have favorited this...
Anjali Atal-Gupta
Associate Director, Regulatory Affairs
Novo Nordisk
Frederike Brühschwein-Mandic
Senior Consultant
confinis ag
Tara Burnett
Vice President of Regulatory Affairs
Monarch Medical Technologies
Robert Cormack
Principal Consultant
NDA Group
Joseph DiDamo
Vice President Global Sales
CQ fluency
Hasnaa FATEHI
Sr. RA Manager
I-MED Pharma Inc.
Mathilda Fienkeng
Division Director
Department of Health and Human Services/Food and Drug Administration
Kuo Jiao
RA Specialist, China/HK
Intuitive Surgical
Ashley Kelleher
Senior Consultant
NSF Health Sciences
Regina Klapperich
Regulatory Affairs Specialist
IMMY
Changhui Li
VP of Business Development
Pharmaron Clinical Services
Josephine Martin
Director, International Regulatory Affairs
Danaher - ENTERPRISE
David McGrath
Vice President of Regulatory & Clinical Affairs
Lucira Health, Inc
Joy Piva
Reg Systems, Ops & Promotion Supervisor
Pacira BioSciences
Anthony Raymond
Vice President of Quality Assurance and Regulatory Affairs
Third Pole Therapeutics
Giselle Reuben
Partner
BLP
Stephanie Seidel
Sr Principal Clinical Evaluation Specialist Evaluation Specialist
Medtronic, Inc. - ENTERPRISE
Kamana Singh
Principal Regulatory Consultant
Opus Regulatory Inc
Andrew Skopek
Account Executive
EXTEDO GmbH
Lindsey Summers
Sr Talent Acquisition Partner
Day One Biopharmaceuticals
Ed Venkat
Global CMC Technical Lead
Gan & Lee Pharmaceuticals USA Corp.
Jie Zhi
Regulatory Affairs Specialist
Smith+Nephew